Search for stocks /

Park Medi World Limited Q3FY26 Concall Decoded: 17% revenue growth, 40% PAT jump – and 93% of revenue riding on Sarkari wallets


1. Opening Hook

Just when everyone thought healthcare was “defensive” and boring, Park Medi World decided to debut on the earnings stage with a 40% PAT jump. Not bad for a business that lives off government schemes and four-and-a-half-month receivable cycles.

This was their first-ever earnings call, and management came armed—with robotics, rate hikes, and a pearl-necklace strategy across Uttar Pradesh. From being a two-decade-old regional hospital chain, they now want to be North India’s affordable healthcare overlord.

Revenue is rising, beds are multiplying, and margins are apparently eternal at 27%. Add to that a handsome CGHS rate hike and a soon-to-be debt-free balance sheet.

But here’s the real drama: 83% of revenue comes from government schemes. Is that a moat—or a tightrope?

Read on. The story gets more interesting.


2. At a Glance

  • Revenue up 17% (9M) – Patients kept coming; government kept approving.
  • PAT up 40% – Operating leverage flexed harder than a gym mirror selfie.
  • EBITDA margin at 26% – Stable, like management’s confidence.
  • Occupancy at 65% – Even after adding 250 beds; not bad for “subdued season.”
  • ARPOB up to ₹27,406 – Robots entered, bills politely followed.
  • ALOS down to 6.34 days – Faster recovery, faster bed rotation.
  • Net debt nearly zero – IPO money worked overtime.

3. Management’s Key Commentary

“This marks Park Medi World’s first ever Earnings Conference Call.”
(Translation: We’ve been making money quietly; now we’ll do it publicly. 😏)

“We are the largest private hospital chain in Haryana.”
(Translation: Regional dominance achieved. Now aiming for UP conquest.)

“Our EBITDA is expected to remain in 26%-27% range for 3, 5, 10 years.”
(Translation: Margins are eternal. Please don’t question the math.)

“We will be completely debt-free by end of February.”
(Translation: IPO proceeds went straight to the bank manager. 💸)

“Our disallowance is 8%-9%, the lowest in the industry.”
(Translation: We argue better with TPAs than others.)

“We have obtained three da Vinci fifth-generation robots.”
(Translation: Affordable hospital, premium toys. 🤖)

“We are not going for government schemes per se.”
(Translation: But if 83% revenue comes from them, who are we to refuse?)

“By FY28, we aspire to reach 5,260 beds.”
(Translation: Growth pipeline locked. Execution pressure unlocked.)


4. Numbers Decoded

Metric9M FY269M FY25GrowthCommentary
Revenue (₹ mn)12,18910,397+17%Volume + ramp-up working
EBITDA (₹ mn)3,1702,826+12%Margins stable at 26%
PAT (₹ mn)1,9681,374+40%Operating leverage magic
Footfall (lakhs)6.65.32+24%Affordable care scaling
ARPOB (₹)27,40625,500+7%Robotics + mix upgrade
Occupancy65%62%+300bpsDespite new beds
Capex per bed (₹ lakh)34–35SameStableCost discipline intact

PAT outpaced revenue—classic leverage play. Robots improved mix, but ARPOB remains “affordable.”


5. Analyst Questions

Q: How does Agra fit the strategy?
A: It’s a pivot in UP’s “pearl and necklace” cluster plan. (Translation: UP takeover in phases.)

Q: Margins sustainable?
A: 26%-27% forever. (Translation: Please don’t expect surprises.)

Q: CGHS hike impact?
A: 12%-15% rate hike; conservatively modeling 7.5%. (Translation: Upside buffer built in.)

Q: Receivable cycle concern?
A: 4.5 months, improving to 4. (Translation: Sovereign risk, not credit risk.)

Q: Why doctor costs rising?
A: Hiring ahead of 660-bed expansion. (Translation: Costs today, beds tomorrow.)


6. Guidance & Outlook

By FY28, bed count jumps from 3,250 to ~5,260. Capex planned: ₹700 crore for 2,010 beds, maintaining ~₹35 lakh per bed (blended).

EBITDA margin guided at 27%, PAT at 17%, ROCE ~21%, ROE ~23%.

CGHS rate hikes (12%-15%) start reflecting fully by FY27 second half. Management is modeling only 7.5% impact. “Conservative accounting,”

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!